Product description

The present Competitive Intelligence Report about Anti-Obesity Peptides and Biologics used to treat obesity and metabolic syndrome provides a competitor evaluation in the field of R&D projects with anti-obesity peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. The database also contains information about discontinued projects. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report includes a compilation of current active projects in research and development of anti-obesity peptides and biologics such as proteins, antibodies, vaccines, cells, and RNA. In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing information on:
-Drug Codes,
-Target / Mechanism of Action,
-Class of Compound,
-Company,
-Product Category,
-Indication,
-R&D Stage and
-additional comments with a hyperlink leading to the source of information. 

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. 

Table Of Contents

Table of Contents

--Obesity Peptides
-Anti-Obesity Biologics
-Corporate RandD Pipelines of Anti-Obesity Peptides and Biologics
-About La Merie

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Drug Discovery and Development Industry: Critical Outcome Technologies Inc. – Product Pipeline Review – Q2 2011

Drug Discovery and Development Industry: Critical Outcome Technologies Inc. – Product Pipeline Review – Q2 2011

  • $ 1 500
  • Industry report
  • October 2014
  • by Global Markets Direct

- Product Pipeline Review - Q2 2011” provides a detailed overview on the Critical Outcome Technologies Inc.’s research and development focus. The report includes data on current developmental pipeline, ...

Drug Discovery and Development in United States: Symphogen A/S – Product Pipeline Review – H2 2011

Drug Discovery and Development in United States: Symphogen A/S – Product Pipeline Review – H2 2011

  • $ 1 500
  • Industry report
  • October 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

Orion Oyj - Product Pipeline Review - 2014

Orion Oyj - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • October 2014
  • by Global Markets Direct

Orion Oyj - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Orion Oyj - Product Pipeline Review - 2014', provides an overview of the Orion Oyj's pharmaceutical research and development ...


3 Companies

Company Profiles

Abengoa S.A.

Spain

BASF SE

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.